Wholesaler “Anti-Competitive” Practices Under Investigation By FTC
This article was originally published in The Pink Sheet Daily
McKesson, Cardinal Health acknowledge ongoing FTC investigation in SEC filings, while AmerisourceBergen declines to comment. Inquiry aims to determine if distributors engaged in practices to limit competition, according to the filings.
You may also be interested in...
Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.
Pharmaceutical manufacturers would increase their costs by $10.5 bil. if they replace wholesalers with a direct distribution system, a report commissioned by the Healthcare Distribution Management Association states
After US President Trump said vaccine developers could develop a COVID-19 vaccine faster if it weren't for politics, Moderna CEO Bancel said no political party has asked the company to move faster or slower.